Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
IE |
|
Esprinet SpA
MIL:PRT
|
IT |
|
W
|
WEX Inc
F:WL9
|
US |
|
K
|
Kinder Morgan Inc
SWB:2KD
|
US |
|
Bitfarms Ltd
XTSX:BITF
|
CA |
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
E
|
Esprinet SpA
F:EP4A
|
IT |
|
F
|
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
|
NZ |
|
R
|
Rotork PLC
F:RO41
|
UK |
|
T
|
Thanulux PCL
SET:TNL
|
TH |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
Precision Drilling Corp
TSX:PD
|
CA |
|
R
|
Resonac Holdings Corp
DUS:SWD
|
JP |
|
Orkla ASA
F:OKL0
|
NO |
Shareholder Yield
Current shareholder yield for AVDL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AVDL Price
Avadel Pharmaceuticals PLC
| Average Annual Return | 17.94% |
| Standard Deviation of Annual Returns | 58.7% |
| Max Drawdown | -90% |
| Market Capitalization | 2.1B USD |
| Shares Outstanding | 98 150 000 |
| Percentage of Shares Shorted | 2.38% |
